Louisa P. Selvadurai

Louisa P. Selvadurai

Auto-generated profile, based on publicly available information

Louisa P. Selvadurai

Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
LSLouisa P. Selvadurai
Louisa P. Selvadurai
IHIan H. Harding
Ian H. Harding
LCLouise A. Corben
Louise A. Corben
NGNellie Georgiou-Karistianis
Nellie Georgiou-Karistianis

13 August 2016 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
LSLouisa P. Selvadurai
Louisa P. Selvadurai
IHIan H. Harding
Ian H. Harding
LCLouise A. Corben
Louise A. Corben
MSMonique R. Stagnitti
Monique R. Stagnitti
ESElsdon Storey
Elsdon Storey
NGNellie Georgiou-Karistianis
Nellie Georgiou-Karistianis

2 January 2024 in The Cerebellum
Verified
Journal Article
Open access
PDF file
LSLouisa P. Selvadurai
Louisa P. Selvadurai
SPSusan L. Perlman
Susan L. Perlman
TATetsuo Ashizawa
Tetsuo Ashizawa
GWGeorge R. Wilmot
George R. Wilmot
COChiadi U. Onyike
Chiadi U. Onyike
JSJeremy D. Schmahmann
Jeremy D. Schmahmann
The Cerebellar Cognitive Affective/Schmahmann Syndrome (CCAS) manifests as impaired executive control, linguistic processing, visual spatial function, and affect regulation. The CCAS has been described in the spinocerebellar ataxias (SCAs), but its prevalence is unknown. We analyzed results of the CCAS/Schmahmann Scale (CCAS-S), developed to detect and quantify CCAS, in two natural history studies of 309 individuals Symptomatic for SCA1, SCA2, SCA3, SCA6, SCA7, or SCA8, 26 individuals Pre-symptomatic for SCA1 or SCA3, and 37 Controls. We compared total raw scores, domain scores, and total fail scores between Symptomatic, Pre-symptomatic, and Control cohorts, and between SCA types. We calculated scale sensitivity and selectivity based on CCAS category designation among Symptomatic individuals and Controls, and correlated CCAS-S performance against age and education, and in Symptomatic patients, against genetic repeat length, onset age, disease duration, motor ataxia, depression, and fatigue. Definite CCAS was identified in 46% of the Symptomatic group. False positive rate among Controls was 5.4%. Symptomatic individuals had poorer global CCAS-S performance than Controls, accounting for age and education. The domains of semantic fluency, phonemic fluency, and category switching that tap executive function and linguistic processing consistently separated Symptomatic individuals from Controls. CCAS-S scores correlated most closely with motor ataxia. Controls were similar to Pre-symptomatic individuals whose nearness to symptom onset was unknown. The use of the CCAS-S identifies a high CCAS prevalence in a large cohort of SCA patients, underscoring the utility of the scale and the notion that the CCAS is the third cornerstone of clinical ataxiology.

6 January 2020 in Human Brain Mapping
Verified
Journal Article
Open access
PDF file
LSLouisa P. Selvadurai
Louisa P. Selvadurai
LCLouise A. Corben
Louise A. Corben
MDMartin Delatycki
Martin Delatycki
ESElsdon Storey
Elsdon Storey
GEGary F Egan
Gary F Egan
IHIan H. Harding
Ian H. Harding
Friedreich ataxia is a progressive neurodegenerative disorder with reported abnormalities in cerebellar, brainstem, and cerebral white matter. White matter structure can be measured using in vivo neuroimaging indices sensitive to different white matter features. For the first time, we examined the relative sensitivity and relationship between multiple white matter indices in Friedreich ataxia to more richly characterize disease expression and infer possible mechanisms underlying the observed white matter abnormalities. Diffusion‐tensor, magnetization transfer, and T1‐weighted structural images were acquired from 31 individuals with Friedreich ataxia and 36 controls. Six white matter indices were extracted: fractional anisotropy, diffusivity (mean, axial, radial), magnetization transfer ratio (microstructure), and volume (macrostructure). For each index, whole‐brain voxel‐wise between‐group comparisons and correlations with disease severity, onset age, and gene triplet‐repeat length were undertaken. Correlations between pairs of indices were assessed in the Friedreich ataxia cohort. Spatial similarities in the voxel‐level pattern of between‐group differences across the indices were also assessed. Microstructural abnormalities were maximal in cerebellar and brainstem regions, but evident throughout the brain, while macroscopic abnormalities were restricted to the brainstem. Poorer microstructure and reduced macrostructural volume correlated with greater disease severity and earlier onset, particularly in peri‐dentate nuclei and brainstem regions. Microstructural and macrostructural abnormalities were largely independent. Reduced fractional anisotropy was most strongly associated with axial diffusivity in cerebral tracts, and magnetization transfer in cerebellar tracts. Multiple mechanisms likely underpin white matter abnormalities in Friedreich ataxia, with differential impacts in cerebellar and cerebral pathways.

15 April 2021 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
LSLouisa P. Selvadurai
Louisa P. Selvadurai
NGNellie Georgiou-Karistianis
Nellie Georgiou-Karistianis
RSRosita Shishegar
Rosita Shishegar
CSCathlin Sheridan
Cathlin Sheridan
GEGary F Egan
Gary F Egan
LCLouise A. Corben
Louise A. Corben

7 July 2016 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
PDF file
PHProfessor David Linley Hare
Professor David Linley Hare
LSLouisa P Selvadurai
Louisa P Selvadurai
JWJerry Q Wang
Jerry Q Wang
HYHo Hin Yau
Ho Hin Yau
MSMadeline J Stone
Madeline J Stone
STSamia Toukhsati
Samia Toukhsati
Background: Depression is common in patients with cardiovascular disease and is a risk marker for increased mortality. The valid and reliable detection of depression is fundamental to the appropriate management of these patients. Aim: The aim of this study was to evaluate the psychometric characteristics of the Cardiac Depression Scale Short Form 1 (DS-SF1) and the Cardiac Depression Scale Short Form 2 (DS-SF2) for screening cardiac outpatients in clinical settings. Methods: Adult cardiac outpatients attending a cardiovascular clinic completed the Cardiac Depression Scale (CDS), two versions of the DS-SF (DS-SF1 and DS-SF2) and the Physical Health Questionnaire 2 (PHQ2-Y/N) prior to their cardiac consultation. Results: Data from 326 patients (224 men; mean±SD age 66.25±14.39 years) were analysed. The DS-SF1 (mean score 16.28±5.70) had good construct validity with the CDS (r=0.77; p<0.0001), adequate convergence with the PHQ2-Y/N (r=0.59; p<0.0001) and good internal consistency (α=0.73). The DS-SF2 (mean score 15.80±6.80) had a better construct validity with the CDS (r=0.84; p<0.0001) and the PHQ2-Y/N (r=0.69; p<0.0001) and better internal consistency (α=0.82). The DS-SF2 showed strong criterion validity with the CDS with a DS-SF2 ⩾15 cut-point yielding 90% sensitivity and 73% specificity (area under the curve 0.92) for detecting depression (CDS ⩾95). Conclusion: These findings confirm the excellent psychometric properties of the DS-SF2 as an ideal tool for screening depression in cardiac patients in clinical practice. The DS-SF2 should be regarded as the definitive version of the DS-SF.